INTRODUCTION
============

Immunity to virus infection involves the complex interplay of many different leukocytes, including natural killer (NK) cells ([@B13]; [@B8]) and CD8 T cells ([@B93]). Pro-inflammatory cytokines, including type I interferon (IFN), can stimulate the activation and proliferation of these cytolytic and cytokine-producing effector cells. Moreover, while CD8 T cell responses are induced by virus-derived peptides in the context of class I major histocompatibility complex (MHC) molecules, NK cell activity can be provoked by interactions of stimulatory NK cell receptors (NKR) such as Ly49H with virally encoded proteins ([@B11]; [@B25]; [@B40]; [@B5]; [@B68]).

Natural killer cell anti-viral function is further regulated by a variety of activating and inhibitory receptors that engage stress-induced proteins ([@B60]) or self-specific MHC antigens ([@B12]) on virus-infected cells. Notably, expression of some NKR is also up-regulated on activated T cells and this expression is often sustained at a high level on virus-specific T cells that have lost functionality or become exhausted in the context of chronic virus infection ([@B83]; [@B21]). One particular NKR, 2B4 (CD244/*slamf4*), contributes to the regulation of both NK cell anti-viral activity and virus-specific CD8 T cell functionality ([@B48]), and has recently been implicated in NK cell regulation of virus-specific T cell responses ([@B85]).

SLAM FAMILY RECEPTORS IN VIRUS INFECTION
========================================

2B4 is a member of the signaling lymphocyte activation molecule (SLAM) family of CD2-related receptors, which includes SLAM (*Cd150/slamf1*), CD48 (*slamf2*), Ly9 (CD229/*slamf3*), CD84 (*slamf5*), NK-T-B-antigen (NTB-A in human, Ly108 in mouse, CD352/*slamf6*), and CD2-like receptor activating cytotoxic cells (CRACC/CS1/CD319/*slamf7*; [@B16]). Each of these receptors, except CD48, encodes two or more cytoplasmic immunoreceptor tyrosine-based switch motifs (ITSM). Tyrosine phosphorylation of this motif facilitates binding of SLAM-associated protein (SAP) family adaptors SAP (*sh2d1a*), EWS--Fli1-activated transcript-2 (EAT-2/*sh2d1b*), and EAT-2-related transducer (ERT/*sh2d1c*; [@B82]). Although most SLAM family receptors engage in homotypic interactions, 2B4 interacts with CD48.

A number of SLAM family receptors are implicated in the pathogenesis of virus infections. The prototypical family member, SLAM, is a cellular receptor for measles virus ([@B77]). CD48 is highly up-regulated on the surface of Epstein--Barr virus (EBV)-infected lymphoblasts and may contribute to viral trafficking ([@B78]). The UL7 protein of human cytomegalovirus contains an immunoglobulin-like domain exhibiting remarkable sequence similarity to Ly9/CD229 ([@B27]). Expression of UL7 in myeloid cells attenuated pro-inflammatory cytokine production.

In contrast to SLAM receptors that are exploited by viruses, NTB-A and 2B4 contribute to effector cell-mediated killing of virus-infected cells. Co-engagement of NTB-A and NKG2D on human NK cells promotes release of lytic granules and lysis of HIV-infected CD4 T cells ([@B86]). However, HIV-1 has evolved mechanisms to evade this SLAM receptor recognition through Vpu-mediated down-modulation of NTB-A expression on infected CD4 T cells ([@B65]). Thus, some SLAM receptors are sufficiently important to the host anti-viral response that viruses may encode proteins to negate their functions.

SAP FAMILY ADAPTORS AND XLP
===========================

Interactions between the ITSM motif of SLAM family receptors and the adaptor protein SAP enables recruitment of the Src family tyrosine kinase Fyn, which facilitates downstream signaling to modulate effector functionality ([@B81]). EAT-2 and ERT serve a similar but mechanistically distinct role ([@B16]).

The SH2D1A gene that encodes SAP is mutated in patients with X-linked lymphoproliferative (XLP) disease such that the SAP polypeptide is absent or dysfunctional ([@B20]). These individuals often present with uncontrolled EBV-induced infectious mononucleosis, characterized by lymphoproliferation, organ failure and death. Infection of *sh2d1a*-deficient mice with lymphocytic choriomeningitis virus (LCMV), *Toxoplasma gondii*, or murine gammaherpesvirus-68 recapitulates many of the disease phenotypes observed in EBV-infected XLP patients, including hyperproliferation of CD8 T cells ([@B24]; [@B90]; [@B91]; [@B17]) and fatal immunopathology ([@B23]). SAP-deficiency also causes defects in long-term humoral immunity ([@B24]; [@B22]; [@B43]) and NKT cell development ([@B19]; [@B53]; [@B57]).

Genetic deficiency of any single SLAM family receptor can recapitulate only a subset of the pathologies of SAP-deficiency and XLP disease ([@B16]). The defects in humoral immunity are associated with changes in T cell production of cytokines ([@B42]; [@B92]), including IL-10, and destabilization of interactions between CD4 T cells and cognate B cells ([@B58]). CD84 and Ly108 play important roles in the conjugation of follicular CD4 T cells and germinal center B cells ([@B15]). The defect in the NKT cell lineage in the absence of SAP can be elicited by combined deletion of SLAM and Ly108, suggesting that these receptors are important in the development of NKT cells ([@B29]). Furthermore, inhibitory signals derived from Ly108 engagement in the absence of SAP substantially impaired NKT cell development ([@B33]).

A remarkable facet of XLP is the specific sensitivity of these patients to infections with EBV. NK and CD8 T cells from these individuals have an impaired capacity to lyse EBV-infected B cells ([@B56]; [@B10]; [@B66]; [@B26]; [@B30]). Among the different SLAM receptors expressed by NK and CD8 T cells, NTB-A and 2B4 substantially contribute to the cytolytic defects of these effectors in XLP ([@B51]; [@B56]; [@B75]; [@B10]). Analysis of female XLP carriers with heterozygous expression of SAP revealed that while memory CD8 T cells specific for cytomegalovirus or influenza can be SAP-expressing or SAP-deficient, EBV-specific T cells are exclusively SAP+ due to NTB-A- and 2B4-mediated inhibitory signaling in the absence of SAP when ligands of these SLAM receptors are engaged on antigen-bearing B cells ([@B55]). Thus, in the context of SAP-deficiency, 2B4 and NTB-A mediate potent inhibition of effector cell cytotoxic function.

THE DUAL-FUNCTION RECEPTOR, 2B4/CD244
=====================================

2B4 is expressed by all NK cells, γδ T cells, basophils, and monocytes as well as a subset of memory-phenotype CD8^+^ αβ T cells ([@B48]). It is currently well accepted that engagement of 2B4 by CD48 can mediate activating as well as inhibitory signals, although the nature of functional dichotomy is a contentious issue. In humans, ligation of 2B4 with specific antibodies or CD48-expressing target cells provides an activating signal for NK cells ([@B74]). In XLP patients who lack functional SAP protein, 2B4 ligation can inhibit NK and CD8 T cell function ([@B51]; [@B56]; [@B75]).

The understanding of the dual nature of 2B4 signaling has been complicated by studies in mice. In contrast to full-length 2B4 which bears four ITSM motifs, alternative splicing in mice generates a short form of 2B4 that contains only one ITSM ([@B71]). Whereas overexpression of full-length 2B4 impaired NK cell cytotoxicity, the short form of 2B4 facilitated redirected lysis of tumor cells ([@B63]). Two isoforms of human 2B4 that differ in a small portion of the extracellular domain were also described, where one facilitated lysis of CD48-expressing target cells and the other did not ([@B46]). *In vitro* studies have provided conflicting results regarding the effect of 2B4 ligation on murine NK and CD8 T cells, with both activating and inhibitory roles described ([@B36]; [@B34]; [@B38]; [@B6]; [@B50]). Mutual expression of both 2B4 and CD48 by the effector and target cells in those assays could facilitate bi-directional signaling as well as interactions between 2B4 and CD48 expressed on neighboring effector cells ([@B34]; [@B38]). Kumar and colleagues ([@B18]) have proposed that the dual-function of 2B4 is dynamically regulated by the ligand density of CD48, 2B4 receptor expression levels, and availability of intracellular SAP protein in NK cells (**Figure [1](#F1){ref-type="fig"}**). Importantly, inhibition of NK cell lysis of self within the hematopoietic compartment is mediated by both 2B4 and MHC class I receptors in a non-redundant fashion ([@B47]). Loss of either 2B4- or MHC-mediated inhibition permitted a partial increase in NK cell lysis, whereas loss of ligands for both systems resulted in greatly elevated NK cell lysis of target cells.

![**Molecular model of the dual-function of 2B4**. **(A)** Engagement of 2B4 by CD48 in the presence of sufficient SAP protein leads to activation of NK or CD8 T cell effector cells. **(B)** Insufficient levels of SAP protein leads to predominantly inhibitory signals downstream of 2B4 on effector cells. **(C)** Increased ligand density or receptor expression can also make SAP expression limiting and result in inhibition of effector cell function.](fimmu-03-00377-g001){#F1}

CONTROL OF NK CELL FUNCTION BY 2B4
==================================

Given that 2B4 could mediate activation of NK and CD8 T cells, it was somewhat surprising that the generation of 2B4-deficient mice underscored an important inhibitory role for murine 2B4 ([@B39]; [@B80]). 2B4-deficient NK cells demonstrated an enhanced capacity to kill CD48-expressing target cells *in vitro* and *in vivo*([@B39]; [@B80]). In the absence of 2B4, NK cells not only lyse hematopoietic tumor cells more efficiently but also begin to target other NK cells ([@B76]) as well as activated CD8 T cells ([@B85]), suggesting that 2B4 is involved in the maintenance of self-tolerance ([@B47]). While 2B4-deficient mice have strengthened the assertion that 2B4 is an important inhibitor of NK cell cytotoxic function (**Figure [2A](#F2){ref-type="fig"}**), no 2B4 deficiencies have been identified in humans, and it is unclear whether ablation of 2B4 expression on human NK cells would produce similar effects to those observed in mice.

![**Modeling the consequences of 2B4 and SAP expression in immunity to persistent virus infection in mice**.**(A)** In a wild-type scenario, virus infection may trigger NK cell lysis of activated CD4 T helper cells and to a lesser extent activated CD8 T cells. This results in less help from CD4 T cells, thereby favoring a loss of CD8 T cell anti-viral function in the context of high levels of replicating virus. Exhaustion of CD8 T cells permits viral persistence with limited immunopathology. **(B)** In the absence of SAP, NK and CD8 T cells exhibit an impaired ability to lyse virus-infected cells, resulting in a loss of viral control. Moreover, we postulate that the immunoregulatory lysis of activated T cells by NK cells may be suppressed in the absence of SAP, thereby contributing to the exaggerated expansion of CD8 T cells and associated fatal immune pathology observed in XLP. **(C)** NK cell lysis of CD8 T cells is enhanced in the absence of 2B4. This causes a severe immune suppression in the context of high viral load, which in turn results in a life-long chronic infection and diminished T cell-mediated tissue damage.](fimmu-03-00377-g002){#F2}

Expression of 2B4 is dynamically regulated on human NK cells during virus infection. One study found that 2B4 expression on NK cells was transiently reduced after HIV infection ([@B54]). Likewise, 2B4 expression was reduced on NK cells in hepatitis C virus (HCV)-infected individuals who demonstrated enhanced control of viral titers after type I IFN therapy ([@B1]). Thus, reduced 2B4 expression on NK cells may be indicative of the direct anti-viral activity of NK cells. Nonetheless, human NK cells up-regulated 2B4 expression and displayed enhanced functional activity following *in vitro* exposure to or intramuscular vaccination with influenza A virus ([@B32]). In addition, heightened transforming growth factor-beta (TGF-β) expression during the immune tolerant phase of persistent hepatitis B virus (HBV) infection was associated with reduced expression of both 2B4 and SAP by NK cells ([@B73]). These low levels of 2B4 and SAP were further correlated with impaired cytotoxic and IFN-γ-producing activities of NK cells. Of note, TGF-β has recently been shown to contribute to the immaturity of NK cells and susceptibility to virus infection during murine infancy ([@B44]). Together, these studies support the idea that 2B4 functions as an activating receptor on human NK cells during virus infection.

EXPRESSION OF 2B4 BY VIRUS-SPECIFIC T CELLS
===========================================

A subpopulation of CD8 T cells with an activated/memory-phenotype express 2B4, which is postulated to play a co-stimulatory role in T cell activation ([@B6]; [@B3]). In the absence of functional SAP (**Figure [2B](#F2){ref-type="fig"}**), 2B4 can also profoundly impair CD8 T cell cytotoxicity against EBV-infected B cells ([@B30]; [@B55]). In a similar fashion, human T-lymphotropic virus I (HTLV-I)-specific CD8 T cells express higher levels of both 2B4 and SAP in patients with HTLV-I-associated neurological disease than in asymptomatic carriers of HTLV-I ([@B28]). Antibody-mediated blockade of 2B4 or knockdown of SAP expression impaired degranulation and IFN-γ production by the HTLV-I-specific CD8 T cells which mediate disease. While this seems to indicate a role for 2B4 in stimulating virus-specific CD8 T cell function, sustained overexpression of 2B4 may also contribute to dysfunction of exhausted virus-specific CD8 T cells during chronic infection.

Chronic viral antigen presentation can drive functional exhaustion and even deletion of virus-specific T cells in both humans and mice ([@B67]). High level expression of 2B4 and other inhibitory receptors has also been observed on exhausted CD8 T cells specific for LCMV ([@B89]), HIV ([@B2]), HCV ([@B7]), and HBV ([@B61]). Blockade of 2B4--CD48 interactions restored murine LCMV- ([@B9]) and human HBV-specific ([@B61]) CD8 T cell effector functions during *in vitro* culture. Moreover, 2B4-deficient LCMV-specific CD8 memory transgenic T cells were maintained at greater levels than wild-type controls during clone 13 infection of mice ([@B88]). Although these results point to a prominent contribution of 2B4 to functional impairment or deletion of virus-specific CD8 T cells (**Figure [2A](#F2){ref-type="fig"}**), another study found that cross-linking of 2B4 on HCV-specific CD8 T cells could either inhibit or enhance effector functionality depending on the expression levels of both 2B4 and SAP within T cells ([@B64]). In addition, antibody-mediated engagement of 2B4 counteracted PD-1 blockade-induced enhancement of HCV-specific CD8 T cell proliferation during *in vitro* culture of human PBMCs. The complex nature of 2B4/PD-1 mediated control of human T cell exhaustion could potentially be explained by our recent findings regarding the role of 2B4 on NK cells in preventing NK-mediated lysis of activated CD8 T cells ([@B85]).

ROLE OF 2B4 IN NK--T CELL CROSSTALK AND VIRAL PATHOGENESIS
==========================================================

In mice, NK cells play an important role in restricting virus replication during murine cytomegalovirus (MCMV) infection ([@B13]). NK cells may also contribute to immunity by regulating the magnitude and function of MCMV-specific T cell responses ([@B14]; [@B72]; [@B62]; [@B41]; [@B4]; [@B70]; [@B49]; [@B52]). NK cells could impair T cell responses by restricting antigen presentation ([@B4]; [@B49]) or through production of anti-inflammatory cytokines like IL-10 ([@B41]). Conversely, other studies reported that NK cells sustained conventional dendritic cell populations to enhance anti-viral T cell responses ([@B62]; [@B70]). However, these immunoregulatory contributions of NK cells are difficult to distinguish from the important role of NK cells in direct control of MCMV replication.

In contrast to MCMV, NK cells are largely dispensable in early control of LCMV infection ([@B13]; [@B87]). We and others recently described an important role for NK cells in determination of viral clearance and disease associated with LCMV infection that involves direct lysis of virus-specific T cells ([@B85], [@B84]; [@B37]). During infection with the clone 13 strain of LCMV, NK cells aided in the development of persistent infection rather than fatal immunopathology through perforin-mediated lysis of activated CD4 T cells, a population which acts to sustain function of the virus-specific CD8 T cells that mediate virus clearance and tissue damage ([@B84]). NK cells also regulate CD4 responses during LCMV Armstrong infection of CD8 T cell-deficient mice ([@B72]).

Natural killer cells can also mediate direct lysis of activated CD8 T cells ([@B59]; [@B69]), but this lysis is much more effective when NK cells are not restrained by 2B4 expression ([@B85]). Through the use of different strains of LCMV and NK cell-deficient mice, Ohashi and colleagues ([@B37]) also demonstrated that NK cells control viral persistence and immunopathology during LCMV infection, but attributed this regulatory effect to perforin-dependent restriction of CD8 T cell expansion without addressing a role for CD4 T cells. Using a modified *in vivo* cytotoxicity assay, we showed that virus infections and pro-inflammatory stimuli (e.g., polyI:C) triggered a rapid, perforin-dependent lysis of activated, but not naive CD4 T cells ([@B84]). NK cell-dependent elimination of CD8 T cells was limited in these assays, suggesting that activated CD4 and CD8 T differ in their susceptibility to NK cell lysis. Notably, activated CD8 T cells expressed more CD48 than their activated CD4 T cell counterparts during LCMV clone 13 infection ([@B84]), and in the absence of 2B4, NK cells displayed an enhanced ability to lyse activated CD8 T cells ([@B85]). As a consequence of dysregulated NK cell lysis of activated CD8 T cells, 2B4-deficient mice suffered a life-long chronic infection with LCMV clone 13 (**Figure [2C](#F2){ref-type="fig"}**). Thus, 2B4--CD48 interactions can prevent NK cell lysis of CD8 T cells and the resulting loss of viral control. In combination with the effects of 2B4 expression by either NK cells or CD8 T cells on the individual anti-viral activities of these effector cells described in the preceding sections, the role of 2B4 in NK cell/T cell crosstalk may be important to consider when evaluating the use of antibody-mediated blockade of 2B4--CD48 interactions in the rescue of the exhausted virus-specific T cell response ([@B9]; [@B64]).

Of note, spontaneous clearance of HCV infection ([@B35]), delayed progression to AIDS during HIV infection ([@B45]), and resistance to HIV infection in chronically exposed sex workers ([@B31]) have all been associated with expression of inhibitory killer immunoglobulin-like receptor (KIR) and their cognate HLA ligands. One interpretation of this observation is that stronger inhibition of NK cell immunoregulatory activity by an inhibitory KIR, or perhaps an inhibitory SLAM receptor such as 2B4, could enhance the virus-specific T cell response against the virus. In fact, the potency of NK cell responsiveness was inversely correlated with the magnitude of HIV-specific T cell responses in a cohort of elite controllers ([@B79]).

CONCLUDING REMARKS
==================

Immunity to virus infection often involves NK cells and virus-specific T cells, whose responses must be regulated in order to prevent excessive lymphoproliferation that could lead to immunopathology, autoimmunity, and cancer. Growing evidence suggests NK cells may be one mechanism which restrains potentially pathogenic effector T cell responses and that such immunoregulation may itself be regulated by the SLAM receptor 2B4. Heightened expression of 2B4 on NK and CD8 T cells during persistent virus infection may contribute to viral pathogenesis by regulating the anti-viral cytokine-producing and cytolytic functions of these anti-viral effectors. Interactions between 2B4 and CD48 may also contribute to anti-viral immunity in an apparent indirect fashion by controlling the ability of NK cells to regulate virus-specific T cell responses. Evidence from a number of different virus infections demonstrates that 2B4-mediated signals can contribute in both beneficial and detrimental manners to viral clearance and immune-mediated disease. An improved understanding of how 2B4 regulates both effector cell function and NK cell/T cell crosstalk would facilitate development of a number of translational avenues. For example, blockade of 2B4/CD48 interactions may enhance effector functions of NK or CD8 T cells during chronic infections. However, one must temper this prospect with concerns over whether 2B4 blockade would ultimately impair adaptive immunity by unleashing NK cell responses against T cells. The latter possibility itself has translational potential. An improved understanding of how and to what extent 2B4 regulates NK cell lysis of activated T cells could be used to generate NK cell-based therapeutic strategies for autoimmune diseases where T cells are active mediators of disease.
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